Prenatal nutrition, epigenetics and schizophrenia risk: can we test causal effects?

We posit that maternal prenatal nutrition can influence offspring schizophrenia risk via epigenetic effects. In this article, we consider evidence that prenatal nutrition is linked to epigenetic outcomes in offspring and schizophrenia in offspring, and that schizophrenia is associated with epigenetic changes. We focus upon one-carbon metabolism as a mediator of the pathway between perturbed prenatal nutrition and the subsequent risk of schizophrenia. Although post-mortem human studies demonstrate DNA methylation changes in brains of people with schizophrenia, such studies cannot establish causality. We suggest a testable hypothesis that utilizes a novel two-step Mendelian randomization approach, to test the component parts of the proposed causal pathway leading from prenatal nutritional exposure to schizophrenia. Applied here to a specific example, such an approach is applicable for wider use to strengthen causal inference of the mediating role of epigenetic factors linking exposures to health outcomes in population-based studies.

[1]  Yanbo Chen,et al.  Effects of MAOA promoter methylation on susceptibility to paranoid schizophrenia , 2012, Human Genetics.

[2]  T. Ekström,et al.  Epigenetic aberrations in leukocytes of patients with schizophrenia: association of global DNA methylation with antipsychotic drug treatment and disease onset , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  Stephan Ripke,et al.  Estimating the proportion of variation in susceptibility to schizophrenia captured by common SNPs , 2012, Nature Genetics.

[4]  G. Davey Smith,et al.  Two-step epigenetic Mendelian randomization: a strategy for establishing the causal role of epigenetic processes in pathways to disease. , 2012, International journal of epidemiology.

[5]  E. Susser,et al.  Adult global DNA methylation in relation to pre-natal nutrition. , 2012, International journal of epidemiology.

[6]  George Davey Smith,et al.  Is epidemiology ready for epigenetics? , 2012, International journal of epidemiology.

[7]  N. Timpson,et al.  Mendelian Randomization: Application to Cardiovascular Disease , 2012, Current Hypertension Reports.

[8]  D. Dunger,et al.  DNA methylation profiling at imprinted loci after periconceptional micronutrient supplementation in humans: results of a pilot randomized controlled trial , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  Mark S. Pearce,et al.  Postnatal Growth and DNA Methylation Are Associated With Differential Gene Expression of the TACSTD2 Gene and Childhood Fat Mass , 2012, Diabetes.

[10]  M. J. Charron,et al.  Minireview: Epigenetic programming of diabetes and obesity: animal models. , 2012, Endocrinology.

[11]  P. Vokonas,et al.  Aging and epigenetics: Longitudinal changes in gene-specific DNA methylation , 2012, Epigenetics.

[12]  D. Maneval,et al.  Genomic DNA Methylation Changes in Response to Folic Acid Supplementation in a Population-Based Intervention Study among Women of Reproductive Age , 2011, PloS one.

[13]  S. Thiagalingam,et al.  Can the schizophrenia epigenome provide clues for the molecular basis of pathogenesis? , 2011, Epigenomics.

[14]  Sang-Woon Choi,et al.  Nutritional influences on epigenetics and age-related disease , 2011, Proceedings of the Nutrition Society.

[15]  J. Mathers,et al.  Maternal folate supply and sex influence gene-specific DNA methylation in the fetal gut. , 2011, Molecular nutrition & food research.

[16]  E. Susser,et al.  Folic acid supplements in pregnancy and severe language delay in children. , 2011, JAMA.

[17]  S. Lewis,et al.  Pre-conception inter-pregnancy interval and risk of schizophrenia. , 2011, The British journal of psychiatry : the journal of mental science.

[18]  Christian U. Krägeloh,et al.  Dietary methyl donor deficiency during pregnancy in rats shapes learning and anxiety in offspring. , 2011, Nutrition research.

[19]  R. Murray,et al.  Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder , 2011, Human molecular genetics.

[20]  Alain Malafosse,et al.  Increased DNA methylation status of the serotonin receptor 5HTR1A gene promoter in schizophrenia and bipolar disorder. , 2011, Journal of affective disorders.

[21]  Linda C. Schmidt,et al.  Prenatal Vitamins, One-carbon Metabolism Gene Variants, and Risk for Autism , 2011, Epidemiology.

[22]  S. Thiagalingam,et al.  Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder , 2011, Schizophrenia Research.

[23]  E. Iversen,et al.  Methylation variation at IGF2 differentially methylated regions and maternal folic acid use before and during pregnancy , 2011, Epigenetics.

[24]  S. Shifman,et al.  The Genetic Variation of RELN Expression in Schizophrenia and Bipolar Disorder , 2011, PloS one.

[25]  David I. K. Martin,et al.  A Sustained Dietary Change Increases Epigenetic Variation in Isogenic Mice , 2011, PLoS genetics.

[26]  Ezra Susser,et al.  Commentary : Advent of sibling designs , 2011 .

[27]  J. Os,et al.  Meta-analysis of MTHFR gene variants in schizophrenia, bipolar disorder and unipolar depressive disorder: Evidence for a common genetic vulnerability? , 2011, Brain, Behavior, and Immunity.

[28]  Yoko Ito,et al.  Maternal diet and aging alter the epigenetic control of a promoter–enhancer interaction at the Hnf4a gene in rat pancreatic islets , 2011, Proceedings of the National Academy of Sciences.

[29]  G. Smith Use of genetic markers and gene-diet interactions for interrogating population-level causal influences of diet on health , 2011, Genes & Nutrition.

[30]  Sarah A. Stern,et al.  A critical role for IGF-II in memory consolidation and enhancement , 2011, Nature.

[31]  Joseph K. Pickrell,et al.  DNA methylation patterns associate with genetic and gene expression variation in HapMap cell lines , 2011, Genome Biology.

[32]  A. Prentice,et al.  Season of Conception in Rural Gambia Affects DNA Methylation at Putative Human Metastable Epialleles , 2010, PLoS genetics.

[33]  George Davey Smith,et al.  Epigenetic Epidemiology of Common Complex Disease: Prospects for Prediction, Prevention, and Treatment , 2010, PLoS medicine.

[34]  Ezra Susser,et al.  Invited commentary: The use of sibship studies to detect familial confounding. , 2010, American journal of epidemiology.

[35]  G. Lewis,et al.  Perinatal folate-related exposures and risk of psychotic symptoms in the ALSPAC birth cohort☆ , 2010, Schizophrenia Research.

[36]  Joseph H. Callicott,et al.  No Effect of a Common Allelic Variant in the Reelin Gene on Intermediate Phenotype Measures of Brain Structure, Brain Function, and Gene Expression , 2010, Biological Psychiatry.

[37]  Arturas Petronis,et al.  Epigenetics as a unifying principle in the aetiology of complex traits and diseases , 2010, Nature.

[38]  D. Grayson Schizophrenia and the epigenetic hypothesis. , 2010, Epigenomics.

[39]  J. Schiffman,et al.  Early developmental milestones and risk of schizophrenia: A 45-year follow-up of the Copenhagen Perinatal Cohort , 2010, Schizophrenia Research.

[40]  Chittaranjan S. Yajnik,et al.  Higher maternal plasma folate but not vitamin B-12 concentrations during pregnancy are associated with better cognitive function scores in 9- to 10- year-old children in South India. , 2010, The Journal of nutrition.

[41]  T. Byers,et al.  Multivitamins, folate, and green vegetables protect against gene promoter methylation in the aerodigestive tract of smokers. , 2010, Cancer research.

[42]  E. Steegers,et al.  Periconceptional Maternal Folic Acid Use of 400 µg per Day Is Related to Increased Methylation of the IGF2 Gene in the Very Young Child , 2009, PloS one.

[43]  J. Kleinman,et al.  Epigenetic mechanisms in schizophrenia. , 2009, Biochimica et biophysica acta.

[44]  A. Ornoy Valproic acid in pregnancy: how much are we endangering the embryo and fetus? , 2009, Reproductive toxicology.

[45]  P. Sham,et al.  Prenatal malnutrition and adult schizophrenia: further evidence from the 1959-1961 Chinese famine. , 2009, Schizophrenia bulletin.

[46]  A. Guidotti,et al.  GABAergic promoter hypermethylation as a model to study the neurochemistry of schizophrenia vulnerability , 2009, Expert review of neurotherapeutics.

[47]  Hein Putter,et al.  Persistent epigenetic differences associated with prenatal exposure to famine in humans , 2008, Proceedings of the National Academy of Sciences.

[48]  Elliot S. Gershon,et al.  Genetic associations with schizophrenia: Meta-analyses of 12 candidate genes , 2008, Schizophrenia Research.

[49]  M. Travisano,et al.  Methyl donor supplementation prevents transgenerational amplification of obesity , 2008, International Journal of Obesity.

[50]  E. Susser,et al.  Congenital anomalies and early functional impairments in a prospective birth cohort: Risk of schizophrenia-spectrum disorder in adulthood , 2008, British Journal of Psychiatry.

[51]  Sun-Chong Wang,et al.  Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. , 2008, American journal of human genetics.

[52]  N. Kato,et al.  Methylation Status of the Reelin Promoter Region in the Brain of Schizophrenic Patients , 2008, Biological Psychiatry.

[53]  G. Smith Assessing intrauterine influences on offspring health outcomes: can epidemiological studies yield robust findings? , 2008, Basic & clinical pharmacology & toxicology.

[54]  R. Jirtle,et al.  Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development , 2007, Proceedings of the National Academy of Sciences.

[55]  S. Lewis,et al.  Schizophrenia and neural tube defects: comparisons from an epidemiological perspective. , 2007, Schizophrenia bulletin.

[56]  A. Guidotti,et al.  Selective epigenetic alteration of layer I GABAergic neurons isolated from prefrontal cortex of schizophrenia patients using laser-assisted microdissection , 2007, Molecular Psychiatry.

[57]  D. Grayson,et al.  DNA Methyltransferase Inhibitors Coordinately Induce Expression of the Human Reelin and Glutamic Acid Decarboxylase 67 Genes , 2007, Molecular Pharmacology.

[58]  C. Allis,et al.  Epigenetics: A Landscape Takes Shape , 2007, Cell.

[59]  S. Faraone,et al.  Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. , 2006, Human molecular genetics.

[60]  Simon Gilbody,et al.  Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. , 2006, American journal of epidemiology.

[61]  P. Magnus,et al.  Cohort profile: the Norwegian Mother and Child Cohort Study (MoBa). , 2006, International journal of epidemiology.

[62]  R. Waterland,et al.  Maternal methyl supplements increase offspring DNA methylation at Axin fused , 2006, Genesis.

[63]  A. Guidotti,et al.  The human reelin gene: transcription factors (+), repressors (-) and the methylation switch (+/-) in schizophrenia. , 2006, Pharmacology & therapeutics.

[64]  Daniel R Weinberger,et al.  Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs. , 2006, Human molecular genetics.

[65]  Paul J. Harrison,et al.  Cellular basis of reduced cortical reelin expression in schizophrenia. , 2006, The American journal of psychiatry.

[66]  P. Turnpenny,et al.  Characteristics of fetal anticonvulsant syndrome associated autistic disorder. , 2005, Developmental medicine and child neurology.

[67]  T. Spector,et al.  Epigenetic differences arise during the lifetime of monozygotic twins. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[68]  A. Guidotti,et al.  Reelin promoter hypermethylation in schizophrenia. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[69]  Kazuo Yamada,et al.  DNA Methylation Status of SOX10 Correlates with Its Downregulation and Oligodendrocyte Dysfunction in Schizophrenia , 2005, The Journal of Neuroscience.

[70]  T. Sanders,et al.  Effect of folic acid supplementation on genomic DNA methylation in patients with colorectal adenoma , 2005, Gut.

[71]  S. Faraone,et al.  Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: A preliminary report , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[72]  M. Webster,et al.  Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains , 2005, Biological Psychiatry.

[73]  A. Petronis The origin of schizophrenia: genetic thesis, epigenetic antithesis, and resolving synthesis , 2004, Biological Psychiatry.

[74]  A. Guidotti,et al.  DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[75]  R. Yolken,et al.  Low maternal vitamin D as a risk factor for schizophrenia: a pilot study using banked sera , 2003, Schizophrenia Research.

[76]  Robert A. Waterland,et al.  Transposable Elements: Targets for Early Nutritional Effects on Epigenetic Gene Regulation , 2003, Molecular and Cellular Biology.

[77]  S. Ebrahim,et al.  'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? , 2003, International journal of epidemiology.

[78]  Dimitris Fouskakis,et al.  Associations between premorbid intellectual performance, early-life exposures and early-onset schizophrenia , 2002, British Journal of Psychiatry.

[79]  G. Varela-Moreiras,et al.  Acute valproate administration impairs methionine metabolism in rats. , 2002, The Journal of nutrition.

[80]  G. Wolff,et al.  Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. , 2002, The Journal of nutrition.

[81]  Ying Chen,et al.  On the epigenetic regulation of the human reelin promoter , 2002, Nucleic Acids Res..

[82]  Richie Poulton,et al.  Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. , 2002, Archives of general psychiatry.

[83]  D. Girelli,et al.  A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[84]  Yogesh K. Dwivedi,et al.  Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. , 2000, Archives of general psychiatry.

[85]  Z. Li,et al.  Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. , 2000, The New England journal of medicine.

[86]  J. Mcgrath Hypothesis: Is low prenatal vitamin D a risk-modifying factor for schizophrenia? , 1999, Schizophrenia Research.

[87]  G. Wolff,et al.  Physiological consequences of ectopic agouti gene expression: the yellow obese mouse syndrome. , 1999, Physiological genomics.

[88]  Hong Wang,et al.  Correction: Prevention of Neural-Tube Defects with Folic Acid in China. , 1999, The New England journal of medicine.

[89]  David I. K. Martin,et al.  Epigenetic inheritance at the agouti locus in the mouse , 1999, Nature Genetics.

[90]  P. McGuffin,et al.  Risk factors for schizophrenia [2] (multiple letters) , 1999 .

[91]  P. Allebeck,et al.  Obstetric complications and the risk of schizophrenia: a longitudinal study of a national birth cohort. , 1999, Archives of general psychiatry.

[92]  R. Murray,et al.  Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. , 1999, Archives of general psychiatry.

[93]  Yogesh K. Dwivedi,et al.  A decrease of reelin expression as a putative vulnerability factor in schizophrenia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[94]  R. Kodell,et al.  Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[95]  A. David,et al.  Premorbid adjustment and personality in people with schizophrenia† , 1998, British Journal of Psychiatry.

[96]  E. Susser,et al.  Neurodevelopmental disorders after prenatal famine: The story of the Dutch Famine Study. , 1998, American journal of epidemiology.

[97]  A. Hofman,et al.  Maternal Use of Antiepileptic Drugs and the Risk of Major Congenital Malformations: A Joint European Prospective Study of Human Teratogenesis Associated with Maternal Epilepsy , 1997, Epilepsia.

[98]  E. Susser,et al.  Schizophrenia After Prenatal Famine-Reply , 1997 .

[99]  J. Os Schizophrenia After Prenatal Famine , 1997 .

[100]  E. Susser,et al.  Schizoid personality disorder after prenatal exposure to famine. , 1996, The American journal of psychiatry.

[101]  M Marmot,et al.  Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort , 1994, The Lancet.

[102]  A. Czeizel,et al.  Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. , 1992, The New England journal of medicine.

[103]  M. Gnant,et al.  Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study , 1991, The Lancet.

[104]  G. Wolff,et al.  Prenatal determination of obesity, tumor susceptibility, and coat color pattern in viable yellow (Avy/a) mice. The yellow mouse syndrome. , 1986, The Journal of heredity.

[105]  M. Dam,et al.  The effects of carbamazepine and valproate on folate metabolism in man , 1984, Acta neurologica Scandinavica.

[106]  M. Susser,et al.  Famine and Human Development: The Dutch Hunger Winter of 1944-1945 , 1975 .

[107]  Ailsa Lyons,et al.  Alcohol imagery and branding, and age classification of films popular in the UK , 2011, International journal of epidemiology.

[108]  J. Stockman Cognitive Function at 3 Years of Age after Fetal Exposure to Antiepileptic Drugs , 2011 .

[109]  P. Visscher,et al.  Rare chromosomal deletions and duplications increase risk of schizophrenia , 2008, Nature.

[110]  E. Susser,et al.  Elevated prenatal homocysteine levels as a risk factor for schizophrenia. , 2007, Archives of general psychiatry.

[111]  J. Stockman Rates of Adult Schizophrenia Following Prenatal Exposure to the Chinese Famine of 1959-1961 , 2007 .

[112]  C. Tamminga,et al.  Risk factors for schizophrenia. Follow-up data from the Northern Finland 1966 Birth Cohort Study. , 2006, World psychiatry : official journal of the World Psychiatric Association.

[113]  A. Paterson,et al.  Monozygotic twins exhibit numerous epigenetic differences: clues to twin discordance? , 2003, Schizophrenia bulletin.

[114]  Paul J. Harrison,et al.  Interstitial white matter neurons express less reelin and are abnormally distributed in schizophrenia: towards an integration of molecular and morphologic aspects of the neurodevelopmental hypothesis , 2003, Molecular Psychiatry.

[115]  S. Fatemi,et al.  Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression , 2000, Molecular Psychiatry.

[116]  Tyrone D. Cannon,et al.  A prospective cohort study of genetic and perinatal influences in the etiology of schizophrenia. , 2000, Schizophrenia bulletin.

[117]  A D Paterson,et al.  Schizophrenia: an epigenetic puzzle? , 1999, Schizophrenia bulletin.

[118]  E. Susser,et al.  Schizophrenia after prenatal famine. Further evidence. , 1996, Archives of general psychiatry.

[119]  R. Matthews,et al.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase , 1995, Nature Genetics.